Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 23 October 1987:
Vol. 238. no. 4826, pp. 536 - 539
DOI: 10.1126/science.3498987
Prev | Table of Contents | Next

Articles

Science, Vol 238, Issue 4826, 536-539
Copyright © 1987 by American Association for the Advancement of Science

articles

Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity

L Greenfield, VG Johnson, and RJ Youle

Department of Microbial Genetics, Cetus Corporation, Emeryville, CA 94608.

Monoclonal antibodies linked to toxic proteins (immunotoxins) can selectively kill some tumor cells in vitro and in vivo. However, reagents that combine the full potency of the native toxins with the high degree of cell type selectivity of monoclonal antibodies have not previously been designed. Two heretofore inseparable activities on one polypeptide chain of diphtheria toxin and ricin account for the failure to construct optimal reagents. The B chains (i) facilitate entry of the A chain to the cytosol, which allows immunotoxins to efficiently kill target cells, and (ii) bind to receptors present on most cells, which imparts to immunotoxins a large degree of non-target cell toxicity. This report identifies point mutations in the B polypeptide chain of diphtheria toxin that block binding but allow cytosol entry. Three mutants of diphtheria toxin have 1/1,000 to 1/10,000 the toxicity and 1/100 to 1/8,000 the binding activity of diphtheria toxin. Linking of either of two of the inactivated mutant toxins (CRM103, Phe508; CRM107, Phe390, Phe525) to a monoclonal antibody specific for human T cells reconstitutes full target-cell toxicity--indistinguishable from that of the native toxin linked to the same antibody--without restoring non-target cell toxicity. This separation of the entry function from the binding function generates a uniquely potent and cell type-specific immunotoxin that retains full diphtheria toxin toxicity, yet is four to five orders of magnitude less toxic than the native toxin is to nontarget cells.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Endosome fusion induced by diphtheria toxin translocation domain.
A. Antignani and R. J. Youle (2008)
PNAS 105, 8020-8025
   Abstract »    Full Text »    PDF »
Detection of Differences in the Nucleotide and Amino Acid Sequences of Diphtheria Toxin from Corynebacterium diphtheriae and Corynebacterium ulcerans Causing Extrapharyngeal Infections.
A. Sing, M. Hogardt, S. Bierschenk, and J. Heesemann (2003)
J. Clin. Microbiol. 41, 4848-4851
   Abstract »    Full Text »    PDF »
Extracellular Bad Fused to Toxin Transport Domains Induces Apoptosis.
M. Ichinose, X.-H. Liu, N. Hagihara, and R. J. Youle (2002)
Cancer Res. 62, 1433-1438
   Abstract »    Full Text »    PDF »
Targeted Toxins.
A. E. Frankel, R. J. Kreitman, and E. A. Sausville (2000)
Clin. Cancer Res. 6, 326-334
   Abstract »    Full Text »
Vascular Protection by Chloroquine during Brain Tumor Therapy with Tf-CRM107.
N. Hagihara, S. Walbridge, A. W. Olson, E. H. Oldfield, and R. J. Youle (2000)
Cancer Res. 60, 230-234
   Abstract »    Full Text »
Targeted toxins.
M W J d. Brok, G C de Gast, J H M Schellens, and J H Beijnen (1999)
Journal of Oncology Pharmacy Practice 5, 149-165
   Abstract »    PDF »
Receptor-mediated uptake of an extracellular Bcl-xL fusion protein inhibits apoptosis.
X.-H. Liu, J. C. Castelli, and R. J. Youle (1999)
PNAS 96, 9563-9567
   Abstract »    Full Text »    PDF »
Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation.
K. U. Frerichs, C. B. Smith, M. Brenner, D. J. DeGracia, G. S. Krause, L. Marrone, T. E. Dever, and J. M. Hallenbeck (1998)
PNAS 95, 14511-14516
   Abstract »    Full Text »    PDF »
Intracellular Targeting with Low pH-triggered Bispecific Antibodies.
V. Raso, M. Brown, and J. McGrath (1997)
J. Biol. Chem. 272, 27623-27628
   Abstract »    Full Text »    PDF »
An In Vitro Model for Toxin-Mediated Vascular Leak Syndrome: Ricin Toxin A Chain Increases the Permeability of Human Endothelial Cell Monolayers.
A. L. Lindstrom, S. L. Erlandsen, J. H. Kersey, and C. A. Pennell (1997)
Blood 90, 2323-2334
   Abstract »    Full Text »    PDF »
Recombinant toxins for cancer treatment.
I Pastan and D FitzGerald (1991)
Science 254, 1173-1177
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)